Floxuridine is a fluoropyrimidine antimetabolite used primarily for the treatment of hepatic metastases of gastrointestinal adenocarcinomas and for the palliation of malignant neoplasms in the liver and… Read more












Floxuridine is a fluoropyrimidine antimetabolite used primarily for the treatment of hepatic metastases of gastrointestinal adenocarcinomas and for the palliation of malignant neoplasms in the liver and gastrointestinal tract. By inhibiting thymidylate synthase, this agent effectively blocks DNA synthesis within target cells. Laboratories utilize this collection of Floxuridine reference standards, which includes the active pharmaceutical ingredient, identified impurities, and synthetic intermediates, to support rigorous quality control and method validation processes. The inclusion of stable isotope labelled compounds provides essential internal standards for sensitive analytical techniques, such as liquid chromatography-mass spectrometry. These reference materials are indispensable for comprehensive impurity profiling, enabling analytical chemists to accurately quantify levels of degradation products and synthetic byproducts throughout the pharmaceutical development and manufacturing lifecycle, thereby ensuring compliance with established regulatory and pharmacopeial specifications.